| 1 |
29552052 | Synergistic Anticancer Effect of Paclitaxel and Noscapine on Human Prostate Cancer Cell Lines. | 2017 Fall |
1 |
| 2 |
19460063 | Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting. | 2010 Mar |
1 |
| 3 |
20933385 | Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: an in vitro and in vivo evaluation study. | 2010 Dec |
7 |
| 4 |
19826044 | Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer. | 2009 Nov 1 |
1 |
| 5 |
16442593 | Randomized Phase II study comparing paclitaxel and carboplatin versus mitoxantrone in patients with hormone-refractory prostate cancer. | 2006 Feb |
2 |
| 6 |
16600800 | Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models. | 2006 May |
1 |
| 7 |
15150548 | Is there a role for chemotherapy in prostate cancer? | 2004 Sep 13 |
1 |
| 8 |
15479494 | Phase II randomized trial of weekly paclitaxel with or without estramustine phosphate in progressive, metastatic, hormone-refractory prostate cancer. | 2004 Sep |
1 |
| 9 |
10604265 | Approaches to the treatment of patients with hormone-sensitive prostate cancer. | 1999 Oct |
1 |